{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:46:15Z","timestamp":1771029975199,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.eimc.2016.06.006","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T12:13:25Z","timestamp":1468930405000},"page":"299-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["\u00bfA qui\u00e9n proponer la profilaxis preexposici\u00f3n al virus de la inmunodeficiencia humana?"],"prefix":"10.1016","volume":"35","author":[{"given":"Oskar","family":"Ayerdi-Aguirrebengoa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Vera-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Puerta-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Raposo-Utrilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rodr\u00edguez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Del Romero-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2016.06.006_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/QAI.0b013e31828ece33","article-title":"Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States","volume":"64","author":"Grohskopf","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2016.06.006_bib0085","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2016.06.006_bib0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2016.06.006_bib0095","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2016.06.006_bib0100","first-page":"586","article-title":"Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.eimc.2016.06.006_bib0105","unstructured":"Centers for Disease Control and Prevention (CDC). Preexposure prophylaxis for the prevention of VIH infection in the Unitate States\u20132014 clinical practice guideline."},{"key":"10.1016\/j.eimc.2016.06.006_bib0110","doi-asserted-by":"crossref","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of tenofovir and emtricitabine in mucosal tissues: Implication for prevention of HIV-1 transmission","volume":"3","author":"Patterson","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.eimc.2016.06.006_bib0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2016.06.006_bib0120","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2016.06.006_bib0125","unstructured":"World Health Organization. WHO Expands recommendation on oral pre-exposure prophylaxis of hiv infection (PrEP). November; 2015."},{"key":"10.1016\/j.eimc.2016.06.006_bib0130","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.15585\/mmwr.mm6446a4","article-title":"Vital signs: Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition- Unitated States, 2015","volume":"64","author":"Smith","year":"2015","journal-title":"M MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.eimc.2016.06.006_bib0135","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/cid\/cit437","article-title":"HIV incidence among men with and those without sexually transmitted rectal infections: Estimates from matching against an HIV case registry","volume":"57","author":"Pathela","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2016.06.006_bib0140","unstructured":"\u00c1rea de vigilancia de VIH y comportamiento de riesgo. Vigilancia epidemiol\u00f3gica del VIH y sida en Espa\u00f1a: Sistema de informaci\u00f3n sobre nuevos diagn\u00f3sticos de VIH y Registro nacional de casos sida. Plan Nacional sobre sida\u2013S.G. de promoci\u00f3n de la salud y epidemiolog\u00eda\/Centro nacional de epidemiolog\u00eda\u2013ISCIII. Madrid; 2015."},{"issue":"Especial Congreso 2","key":"10.1016\/j.eimc.2016.06.006_bib0145","first-page":"20","article-title":"Prevalencia del VIH en HSH en Madrid","volume":"33","author":"Rodr\u00edguez","year":"2015","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2016.06.006_bib0150","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/S2352-3018(15)00056-9","article-title":"Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: A mathematical modelling study","volume":"3","author":"Punyacharoensin","year":"2016","journal-title":"Lancet HIV"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X16301525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X16301525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T13:23:32Z","timestamp":1530019412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X16301525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0213005X16301525"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2016.06.006","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00bfA qui\u00e9n proponer la profilaxis preexposici\u00f3n al virus de la inmunodeficiencia humana?","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2016.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}